Abstract
Cell size regulation in bacteria is a function of two basic cellular processes: the expansion of the cell envelope and its constriction at spatially defined points at what will eventually become the division plane. In most bacterial species, both cell wall expansion and restriction are dependent on peptidoglycan (PG), a structural polymer comprised of sugars and amino acids that imparts strength and rigidity to bacterial membranes. Pathogenic Chlamydia species are unique in that their cell walls contain very little PG, which is restricted almost entirely to the apparent division plane of the microbe’s replicative forms. Very little is known about the degree to which PG affects the size and shape of C. trachomatis during its division process, and recent studies suggest the process is initiated via a polarized mechanism. We conducted an imaging study to ascertain the dimensions, orientation, and relative density of chlamydial PG throughout the organism’s developmental cycle. Our analysis indicates that PG in replicating C. trachomatis can be associated with four, broad structural forms; polar/septal disks, small/thick rings, large rings, and small/thin rings. We found that PG density appeared to be highest in septal disks and small/thick rings, indicating that these structures likely have high PG synthesis to degradation ratios. We also discovered that as C. trachomatis progresses through its developmental cycle PG structures, on average, decrease in total volume, indicating that the average cell volume of chlamydial RBs likely decreases over time. When cells infected with C. trachomatis are treated with inhibitors of critical components of the microbe’s two distinct PG synthases, we observed drastic differences in the ratio of PG synthesis to degradation, as well as the volume and shape of PG-containing structures. Overall, our results suggest that C. trachomatis PG synthases differentially regulate the expansion and contraction of the PG ring during both the expansion and constriction of the microbe’s cell membrane during cell growth and division, respectively.
Introduction
All Chlamydia species share a biphasic developmental cycle (Figure 1a). These obligate intracellular pathogens alternate between a small (~0.3μm) extracellular, infectious form (Elementary Body or EB) and a larger (~1μm), intracellular, replicative form (Reticulate Body or RB; ). EB membranes contain a number of highly cross-linked (disulfide bonded), cysteine-rich outer membrane proteins that provide the microbe with the structural rigidity needed for maintaining cell integrity in an extracellular environment. Upon coming into contact with a host cell, EBs are rapidly internalized into a vacuole (termed an “inclusion”) and utilize a type III secretion system (T3SS) to secrete a wide assortment of effector proteins into the cell cytoplasm. Within ~8–12h, EBs begin differentiating into RBs, during which time the outer membrane proteins begin to un-crosslink, the cells enlarge, and begin to replicate. Temporal gene expression largely determines when this transition occurs (), and the expression of early, mid, and late genes roughly corresponds to different phases of the chlamydial developmental cycle (). Sixteen to twenty-four hours after entering a host cell these RBs begin to asynchronously decrease in size (), transition into intermediate forms (IBs), express cysteine-rich outer membrane proteins, and transition into EBs. EBs then exit the cell by one of two routes: (i) the inclusion expands enough to lyse the cell, expelling the newly formed EBs, or (ii) portions of the inclusion begin to “bleb off” into the extracellular environment in a process termed extrusion (). The disruption of either of these transition events (EB to RB or RB to EB) effectively halts the developmental cycle and prevents the bacterium from entering new host cells ().
Figure 1
Peptidoglycan (PG) is an essential structural element in the vast majority of bacterial species (). This sugar/amino acid polymer encases the bacterium in a mesh-like layer (the sacculus) that provides strength, rigidity, and shape to bacterial cell walls. PG also acts to tether the inner and outer membranes together in Gram-negative bacteria () and thus aids in the constriction of the bacterial septum during division (). Nascent PG synthesis is spatially and temporally restricted within bacterial cells via two known molecular complexes, each relying on a principle, filament-forming protein: the FtsZ complex (“divisome”), which is associated with septal PG synthesis required during cell division, and the MreB/Rod complex (“elongasome”), which is primarily associated with lateral cell wall synthesis. Members of the Chlamydiae do not encode FtsZ and originally were thought to completely lack PG (; ; ; ). Despite the apparent absence of PG, these microbes are still susceptible to PG-targeting antibiotics (; ; ; ; ) and this discrepancy was termed the “chlamydial anomaly” (). Unlike all other bacterial species described to date, members of the Chlamydiales do not synthesize a PG cell wall or “sacculus” but maintain their PG in a narrow band corresponding to the septal division plane (, ). This PG “ring” plays an active role in Chlamydia cell division () and is synthesized by a rudimentary MreB/Rod complex. While some Chlamydia-like bacteria still utilize a PG sacculus (), evolution within an intracellular environment may have removed the selective pressure to maintain a sacculus for osmotic protection (; ), thus allowing other members of the Chlamydiales to survive with only enough PG for carrying out the cell division process. As chlamydial PG is immunostimulatory and signals through cytoplasmic NOD receptors (), it has been proposed that some Chlamydia species have evolved to limit PG utilization, thereby decreasing the pathogen’s immunogenic profile (; ; ).
It has long been held that Chlamydia species, like most other bacteria, divide by “classical” binary fission () in which a parent bacterial cell gives rise to two daughter cells of equal size and volume. However, the very first observations of Chlamydia species examined by EM noted that the two membrane-enclosed segments within each RB were either “equal or unequal” in size (). Recent studies suggest that the beginning of the chlamydial division process resembles a polarized mechanism akin to budding, in which a daughter cell initially expands out from one pole of the RB (; ; ). During this initial, polarly restricted expansion of the bacterial membrane, PG localizes to the intermediate zone between the parent and newly expanding daughter cell (; ). A number of earlier studies have reported an initial asymmetry during the division process in a wide array of Chlamydia species (; ; ; ; ; ), including some from human endocervical samples (; ). Despite this initial asymmetry, the chlamydial division process eventually results in two equally sized daughter cells, indicating the presence of an underlying, cell size regulatory mechanism. While “budding-like” division has been described in members of the Planctomycetes (; ; ), this process differs significantly from “polarized division” in that it gives rise to daughter cells of different sizes. Polarized division (or “polarized binary fission”) has not been described outside members of the Chlamydiaceae to date, and it is unclear how the process is regulated and what benefit it might confer to pathogenic Chlamydia species.
Cell size maintenance in bacteria is principally a function of opposing cellular activities: (i) fatty acid biosynthesis and (ii) the competing processes of localized PG synthesis, remodeling, and degradation. Fatty acids are required for the generation of phospholipids and lipopolysaccharide that compose bacterial cell membranes, whereas PG remodeling is critical for maintaining bacterial cell shape, rigidity and enables the terminal step in the division process (septation). Because pathogenic Chlamydia species lack a PG sacculus (, ), but maintain septal PG for cell division and differentiation, the size of a given Chlamydia RB should therefore be dependent on the corresponding rates of PG and fatty acid biosynthesis. Most bacteria control cell size utilizing the second messenger (p)ppGpp, which regulates fatty acid biosynthesis (). Under nutrient starvation conditions, cell size is reduced close to three-fold in most bacterial species (), resulting from the accumulation of ppGpp. By comparison, Chlamydia species do not encode the enzymes necessary for ppGpp synthesis (), and in response to nutrient starvation, RBs frequently increase in size (; ). When fosfomycin is used to inhibit PG biosynthesis in the Chlamydia-related bacterium Waddlia chondrophila, bacterial cells similarly continue to increase in size (). By comparison, cell division inhibitors that completely abolished PG synthesis in C. trachomatis effectively limit cell size expansion (); however, this is likely due to their effect on global protein synthesis (; ). Another study has reported that C. trachomatis RBs undergo cell size reduction prior to differentiating into their non-replicative, infectious forms (), effectively linking the processes of cell size regulation, division, and differentiation. The processes of DNA replication and septation are decoupled in C. trachomatis (); however, the inhibition of replication has been shown to directly affect PG septal formation (). The exact mechanism by which RBs regulate their division process and by proxy their cell size, remains unknown.
In this study, we set out to determine how PG synthesis influences the size and shape of chlamydial RBs throughout the pathogen’s division process and developmental cycle. We conducted an analysis of the localization and relative synthesis activity of PG throughout Chlamydia’s developmental cycle and compared our data to predictions based on assumptions inherent to both the polarized division model and cell size reduction-preceding-differentiation model of chlamydial development.
Materials and Methods
Bacterial Strains and Cell Lines
Chlamydia trachomatis serovar L2 strain 434/Bu was provided by Dr. Anthony Maurelli (University of Florida). Chlamydial infections were carried out in HeLa cells or L2 cells (also provided by Dr. Anthony Maurelli) unless otherwise noted. The L2 mouse fibroblast cells and HeLa cell lines were passaged in high glucose Dulbecco’s modified Eagle medium (DMEM, Gibco) and 10% fetal bovine serum (FBS, HyClone). HEK-Blue-hNOD1 and -Null1 cells were purchased from InvivoGen and propagated according to the manufacturer’s instructions.
Chlamydial Infections
HeLa cells were plated on glass coverslips in 24 well tissue culture treated plate (Costar) at a confluency of ~70–80%. Cells were infected with C. trachomatis L2 434/Bu in cold Dulbecco’s modified Eagle medium (DMEM; Gibco; 250μl per well) and placed on a rocker in the 37°C tissue culture incubator for 2h. Subsequently, the DMEM was removed and replaced with DMEM supplemented with 10% FBS (HyClone) and 1x MEM Non-Essential Amino Acids Solution (Sigma; 250μl per well). The following aberrance inducing conditions were tested in this study and added at either the time of infection or at 22hpi: 10μM piperacillin, 10μM mecillinam, 10μM penicillin G, 125μM MP265 (polymerization inhibitor of the bacterial cytoskeletal protein MreB), and 3μM chloramphenicol.
Labeling of Chlamydial Peptidoglycan
HeLa cells were infected with C. trachomatis L2 434/Bu at an MOI of 1 unless otherwise stated. Cells and replicating intracellular Chlamydia were grown in the presence of the PG intercalating reagent ethynyl-D-alanyl-D-alanine (EDA-DA) at a concentration of 1mM. At 24 hpi, cells were washed 3 times with 1X PBS, permeabilized with methanol and 0.5% Triton X (5min each) prior to blocking with 3% Bovine Serum Albumin (BSA) for 1h and antibody labeling. Click chemistry was carried out to link the PG-associated EDA-DA with conjugated fluorophore Azide-Alexa Fluor 488, as previously described (, ). The chlamydial Major Outer Membrane Protein (MOMP) was labeled with anti-MOMP primary antibody (goat) and secondary antibody (donkey anti-goat Alexa Fluor 594) at the dilutions 1:500 and 1:1,000, respectively. All coverslips were mounted on slides with ProLong Gold Antifade Mounting Media and stored in the dark at 4°C prior to imaging.
Imaging and Analysis of Peptidoglycan and MOMP-Labeled Objects
All imaging was conducted with a Zeiss ELYRA PS.1 in Structured Illumination (SIM) mode. Settings were fixed at the beginning of image acquisition, Z-stacks were collected for all images taken, and the same parameters were applied for collecting and post-processing all images taken within each experiment. All SIM processing was conducted in RAW fluorescent units (as opposed to averages or percentile standardizations), thus maintaining readouts well below maximum threshold and eliminating the potential for post-processing steps to approach pixel saturation. All post-image processing was conducted on Zen 2012 (Carl Zeiss) software. ImageJ was used for all subsequent image analysis utilizing the FIJI addon “3D Objects Counter” to identify the 3-dimensional spatial constraints of all PG-containing objects within individual C. trachomatis inclusions. Relative object volumes were estimated based off of pixel fluorescence data present throughout a Z-stack. Pixels were assigned a “1” or a “0” value based on a common threshold setting applied to all images examined. A composite of all connected “1” pixels through x, y, and z planes was thus constructed from that imaging data. Each PG-labeled object was assigned an estimated volume (in μm3), fluorescence mean intensity (average pixel intensity), and integrated density (the sum of all pixel intensity measurements comprising an object). Object size thresholding was restricted to objects larger than 0.001 μm3, the detection limit of this approach, corresponding to a single pixel. Statistical significance values were calculated utilizing a one-way ANOVA coupled with a multiple comparisons test with each condition compared with the untreated control group. Inclusion diameters were calculated using the average of the maximum diameter visible from all corresponding z planes and the diameter of a line perpendicular to this maximum diameter.
Infection of HEK-Blue hNOD1 and Null1 Cells With Chlamydia trachomatis and NF-κB Reporter Assay
HEK-Blue cells expressing the hNOD1 receptor and carrying the NF-kB SEAP (secreted embryonic alkaline phosphatase) reporter gene (InvivoGen) were used according to the manufacturer’s instructions and adapted to assess NOD1-specific NF-κB activity during infection with C. trachomatis, as previously described (). Briefly, 3 × 105 cells/mL of HEK-Blue hNOD1 or Null1 cells were plated in 96-well plates (total reaction volume of 200μl per well, ~6.0 × 104 cells per well) and allowed to adhere for 6h at 37°C. These cells were subsequently infected with C. trachomatis L2 434/Bu at a MOI of ~1. Plates were centrifuged for 1h at 2,000g to enhance the synchronization of infections and then incubated in a CO2 incubator at 37°C. Supernatants were collected at the designated time points for subsequent analysis of SEAP activity. A colorimetric reporter assay was then utilized in order to quantify the abundance of SEAP in cell supernatants. Twenty microliter of supernatants collected from infected cells were added to 180μl of the SEAP-detection solution (InvivoGen) followed by incubation at 37°C for ~8h. SEAP enzymatic activity was then quantified using a plate reader set to 650nm. Infected cells were compared to uninfected controls, as well as infected cells that had been treated with various PG-targeting antibiotics. Uninfected cells treated with the known NOD1 signaling ligand Tri-DAP (1μg/ml) were used as a positive control. All experiments were carried out in parallel in the HEK-Blue Null1 cell line, which contains the empty expression vector but lacks hNOD1. HEK-Blue NOD1 SEAP and Null1 reporter assays were carried out independently in biological triplicate, statistical analysis was conducted by 2-way ANOVA, and significance values were analyzed utilizing Sidak’s multiple comparisons test. Values plotted are means of the raw OD650 measurements.
Results
Peptidoglycan Structures Differ in Their Volume and Labeling Intensity Within Chlamydia trachomatis Inclusions
To determine the extent to which PG labeling can be utilized to investigate the stages of the Chlamydia division process, we carried out a mapping study of all PG-containing objects within 100 chlamydial inclusions. Infected cells were incubated with the PG intercalating agent ethynyl-D-alanyl-D-alanine (EDA-DA; ) and allowed to grow for 24h, at which time the cells were fixed, permeabilized, incubated with cupric sulfate and an azide-conjugated fluorophore in a click chemistry reaction. Cells were subsequently immunolabeled with a monoclonal antibody specific for the pathogen’s Major Outer Membrane Protein (MOMP). Labeled cells were then imaged by structured illumination microscopy (SIM), Z-stacks of infected cell monolayers were collected, all EDA-DA labeled objects within each inclusion were counted and assigned corresponding spatial dimensions and labeling intensities (Figures 1b–d).
We have reported previously that septal (“ring”) PG in Chlamydia species is not uniform and can differ in diameter between individual bacterial RBs (). We have also noted that peptidoglycan in C. trachomatis is transient and can dissociate rapidly when the cell division apparatus is inhibited () or when “persistence” is induced utilizing various stressors (). PG labeling intensity is a function of multiple cellular processes: (i) the uptake of the labeling reagent, (ii) the relative rates of its incorporation during peptidoglycan biosynthesis and dissociation during peptidoglycan degradation, and (iii) the relative density of the PG-containing structure. Having observed differences in PG labeling intensities when PG biosynthesis was directly interrupted, we questioned whether PG rings differed significantly in their labeling intensities throughout chlamydial development. We reasoned that if differences exist in either (1) the rates of PG synthesis and PG degradation or (2) the density of PG produced between bacteria at different stages of development, then we should be able to observe corresponding differences in PG labeling intensity. To investigate this question, we plotted PG-containing object volume against object fluorescence integrated density for all labeled objects within 15 chlamydial inclusions (Figure 1e). The overall data fit well within the linear range (R2=0.969), and we found that as object volume increased, so too did the variance in mean fluorescent intensity labeling, as judged by the distance of each data point relative to the calculated linear regression line for the data set. As integrated density is a function of a labeled object’s volume and mean fluorescent intensity, we reasoned that these differences in the labeling intensities of larger objects could signify differences in either object shape, the density of the labeled PG within objects, or the kinetics of PG assembly and degradation occurring in these structures.
PG Ring Volume and Labeling Intensities Vary Between RBs at Different Stages of the Chlamydia Division Process
To assess whether the divergence in PG labeling observed in the pooled inclusion data was representative of RB populations within individual inclusions, we repeated our examination for each inclusion from the previous analysis and plotted PG-labeled object volume and intensity measurements for every labeled object within each inclusion. We found similar levels of variance in object mean fluorescent intensity in all inclusions, and examining inclusions containing fewer bacteria allowed us to focus on individual PG-containing objects and compare their relative shapes and staining intensities. For both smaller (<5μm diameter, Figure 2A) and larger (≥5μm, Figure 2B) inclusions, “brighter” objects (high mean fluorescent intensity) appeared to orient as disks or smaller, compact rings (Figures 2A,B; red/yellow), whereas “dimmer” objects (low mean fluorescent intensity) varied in ring diameter and appeared thinner across the ring width (Figures 2A,B; blue/green). Striking differences in labeling intensity between objects of similar volume were found to be the result of relative differences in the apparent thickness of otherwise smaller rings (Figure 2B, lower left panel, objects 56 and 60). Based on these three defining features (shape, volume, and labeling intensity), we found that PG orientation within intracellular chlamydial RBs fit within four broad categories: (i) disks, (ii) small diameter/large volume (≥0.06μm3) rings, (iii) large diameter /large volume (≥0.06μm3) rings, and (iv) small diameter/small volume (< 0.06μm3) rings.
Figure 2
We hypothesized that objects with higher-than-average labeling intensities represented PG undergoing rapid synthesis, as would be predicted during septation, the terminal step in bacterial cell division (Figure 2C). However, because it has been reported that Chlamydia PG initially localizes to the interface between parent and daughter cell during the initial polar expansion of the cell membrane (; ), we wanted to know whether active PG synthesis was also occurring at this earlier stage of the division process (Figure 3a). We examined PG-labeled objects in 100 labeled inclusions and found that most inclusions larger than 5μm in diameter contained between one to three examples of RBs in which PG was asymmetrically bisecting the bacterial cell, consistent with the “polar budding” phenotype (Figures 3b–d). PG-labeled objects in cells that appeared to be undergoing polar expansion had labeling intensities higher, on average, than all other objects within the inclusions (Figures 3b–d), similar to PG-labeled objects in cells undergoing septation (Figure 3e). Taken together, these data indicate that EDA-DA incorporated PG is maximally present during both the budding and septation phases of chlamydial division.
Figure 3
PG Ring Volume and Labeling Intensity Is Directly Affected by Protein Synthesis, MreB Polymerization, and Penicillin-Binding Protein Activity
Given the differences we observed in labeling intensities for individual PG structures within RB populations, we next wanted to examine how changes to basic molecular processes affected our PG-labeled objects. We hypothesized that object size and shape were dependent on Chlamydia’s division cycle and that object labeling intensity, as measured by our assay, is affected by two distinct processes: PG synthesis and degradation. While each of these activities requires protein synthesis, we reasoned that we could delineate which was the prevailing process by incubating cells with a short, sub-inhibitory dose of the protein synthesis inhibitor chloramphenicol (Cm) and measuring the resulting changes in mean object volume and labeling intensity. Cm treatment had no discernable effect on average object volume but did result in decreasing object labeling intensity (Figures 4A–C). By comparison, similar treatment with MP265, an MreB polymerization inhibitor that blocks MreB-dependent PG synthesis in C. trachomatis (), results in large reductions in both PG object volume and labeling intensity (Figures 4B,C). The decrease in mean intensity during Cm treatment suggests that the balance between synthesis and degradation shifts toward turnover when protein synthesis is reduced, however, this degradation appears to be uniform across the entire PG ring as opposed to being localized to specific points on the ring. This may be a result of the timing and kinetics of the assay as previous reports investigating the effects of the inhibition of MreB polymerization on PG in C. trachomatis noted an initial reduction in PG ring labeling intensity that was subsequently followed by PG ring degradation ().
Figure 4
Previous studies investigating the effects of the ß-lactam antibiotic ampicillin on Chlamydia ring morphology have demonstrated that while EDA-DA incorporation continues to occur, PG-labeled objects exhibit an enlarged, irregular morphology (, ; ; ). This was originally thought to be due to the fact that transpeptidation is not required for the incorporation of EDA-DA, as this process occurs in the cytoplasmic space during Lipid II biosynthesis (). We wanted to further examine this irregular PG phenotype and establish whether it is unique to the inhibition of specific PBPs in Chlamydia. We incubated Chlamydia-infected cells for 2h in the presence of inhibitors specific for PBP2 (mecillinam; mec), PBP3 (piperacillin; pip), or both (penicillin G; penG) and compared the relative volume and intensities of PG-positive objects with an untreated control group. When PBP2 activity was inhibited alone, or in conjunction with PBP3, we saw a significant reduction in mean object volume (Figures 4A,B), however, object mean fluorescent intensity did not decrease (Figure 4C). Conversely, inhibition of PBP3 resulted in an increase in object volume (Figure 4A, bottom left panel). The effect was so robust that our subsequent imaging analysis could not distinguish a large number of individual objects, resulting in their removal from the analysis, and a subsequent “low confidence” score in our reported average volume for this treatment condition (Figure 4B). When both PBP2 and PBP3 are inhibited together, both object volume and object labeling intensity was significantly reduced. As an object’s integrated density (IntDen) is a function of both its volume and its labeling intensity, these measurements largely tracked with our mean fluorescent intensity measurements (Figures 4C,D) with the notable exception of the Mecillinam-treated group. Given the relative expansion of the PG ring when PBP3 was inhibited and the relative disassembly of the PG ring when PBP2 was inhibited, our observations suggest that PG structure in C. trachomatis is a function of these two differential PG synthases.
We next wanted to ensure that the loss of PG labeling under our treatment with ß-lactam antibiotics was the result of defects in PG assembly, rather than resulting from the complete inhibition of PG biosynthesis. Gram-negative bacteria are known to continue to synthesize lipid II and attempt to assemble PG despite a block on transpeptidation (). This has previously been demonstrated with D-cycloserine () and ampicillin () in C. trachomatis, utilizing a NOD reporter assay. We examined each treatment condition in a NOD1-signaling reporter cell line that reacts to PG-derived muropeptides produced by C. trachomatis that contain meso-diaminopimelic acid (mDAP; ). Similar to ampicillin, we found that C. trachomatis continues to generate mDAP-containing muropeptides in the presence of all other ß-lactam antibiotics (Figure 5), indicating that the absence of labeling in our mec and penG treatment conditions is not the result of an absence of Lipid II production. Coupled with our imaging analysis, these data suggest that chlamydial PBP2 and PBP3 activities are associated with different stages of the bacterium’s cell division process. Interestingly, we also found that only the complete interruption of PG assembly (via penicillin G) or PG biosynthesis (via D-cycloserine) significantly enhanced NOD1-ligand production and release. PG-derived muropeptide turnover was not significantly enhanced when PBP2 or PBP3 functions were selectively inhibited with mecillinam and piperacillin, respectively.
Figure 5
Average Peptidoglycan Ring Volume and Labeling Intensity Decreases as Chlamydia trachomatis Progresses Through Its Developmental Cycle
We next sought to examine PG-labeled objects in the context of the C. trachomatis developmental cycle. For this analysis, cell monolayers were infected via rocking, as opposed to centrifugation, and infection inoculates were left on the cell layers in order to achieve an asynchronous population of C. trachomatis infected cells all at different stages of the microbe’s developmental cycle. Cells were fixed, stained, imaged, and processed as before, but inclusion size measurements were also collected as an indicator of the stage of development that individual inclusions had reached by the point of fixation. Chlamydia inclusions fuse and expand throughout the pathogen’s developmental cycle and larger inclusions result from longer incubation times.
An analysis of inclusion dimensions revealed a relatively good distribution of inclusion sizes present in our study population (Figure 6A), which exhibited a slight bimodal distribution (Figure 6B). As replicating Chlamydia RBs should increase logarithmically over time, we hypothesized that PG-labeled objects should similarly exhibit a logarithmic function when plotted against inclusion diameter. We observed this exact phenomenon (Figure 6C), strengthening our confidence that inclusion diameter could be used as a readout for the relative age of the bacterial population within. In examining PG-labeled objects from individual inclusions, we determined that object volumes ≤0.1μm were of higher confidence than object volumes ≥0.1μm, due to the vast majority of the larger objects resulting from multiple, overlapping smaller objects being mistakenly reported as single large objects. We examined the presence of these larger objects throughout the range of inclusion diameters present in our data set, expecting to find more per inclusion later in development, when the inclusions contain significantly more labeled objects. Surprisingly, we found the reverse to be true, with the ratio of smaller to larger objects increasing as inclusion diameter increased (Figure 6D).
Figure 6
Previous reports have indicated that as Chlamydia proceeds through its developmental cycle its replicative forms (on average) decrease in size with subsequent division events (). According to this model, a gradual reduction in RB size eventually enables C. trachomatis to drop below a critical size threshold, enabling the pathogen’s replicative form to convert to its infectious form (Figure 7A). This model has been difficult to test utilizing fluorescence microscopy, as delineating individual bacterial cell boundaries within densely packed, intracellular inclusions are challenging. However, given our success mapping PG-labeled objects associated with individual Chlamydia RBs, we sought to validate this model by conducting an analysis of the relative volume and density of PG-labeled structures throughout the course of Chlamydia’s developmental cycle.
Figure 7
Given the size-reduction-precedes-differentiation model’s constraints, we hypothesized that PG object volume should significantly decrease over time, as a result of Chlamydia progressing through its development, while labeling intensity should increase, as it has been proposed that C. trachomatis maximizes its replication rate by the mid-stage in its development. We plotted average object volumes, integrated densities, and mean fluorescent intensity values against the diameters of each inclusion for both sets of objects collected (< 0.1μm3 and>0.1μm3). For objects ≤0.1μm3 we found that average object mean fluorescent intensity (Figure 7B), object integrated density (Figure 7C), and object volume (Figure 7D) all decreased as inclusion diameters increased. For objects >0.1μm3, no similar decrease in average object integrated density or volume was observed as inclusion diameter increased (Figures 7C,D). Interestingly, objects >0.1μm3 did exhibit a similar trend as smaller objects in that their mean fluorescent intensities appeared to significantly decrease as inclusion diameter increased (Figure 7B). Overall, these observations appear to conform to the size-reduction-before-differentiation model in that average PG volume decreases over the span of a developmental cycle.
Discussion
Cell size regulation is critical for bacterial species, enabling microbes to respond to favorable and detrimental changes in their respective environments. The mechanism(s) employed for regulating cell size are predominantly well-conserved in bacteria; however, the notable exception is members of the Chlamydiales that lack sacculi (, ). For these organisms, cell expansion is presumably limited only by fatty acid biosynthesis and the rate of PG-dependent cell division, rather than the remodeling of a PG-containing cell wall. When PG synthesis is inhibited in these organisms, cell size increases dramatically, indicating that cell size reduction in Chlamydia species is largely dependent on the rate of cell division. C. trachomatis is capable of halting its biphasic developmental cycle during unfavorable environmental conditions by simply inhibiting PG biosynthesis (; ; ). This prevents cell size-reduction, as well as completely inhibits PG synthesis, enabling the degradation of the PG ring when the pathogen is subjected to iron- and/or tryptophan depletion (), two conditions utilized by the innate immune system to ward off intracellular bacteria (). These two cell stressors are generally associated with the induction of the pathogen’s aberrant/ persistent state (Figure 1A; ).
While members of the Chlamydiae encode a number of components involved in localized PG synthesis, they lack the central protein responsible for directing the septal division machinery in most other bacterial species; FtsZ (). However, these organisms do possess the fundamental elements of the side wall (RodA (), PBP2) and septal (FtsW (), PBP3) PG polymerases. The exact role(s) played by each of these two complexes in the context of i) the newly characterized stages of the Chlamydia division process (Figure 8A) and ii) the microbe’s biphasic developmental cycle is only now being actively investigated. Our analysis of the PG composition of 1,000 of chlamydial RBs has led us to conclude that the Chlamydia division process can be broken into four stages based on PG localization and intensity measurements: priming/initiation, budding, resting, and septation (Figure 8A). Our observations are consistent with previous reports describing an initial budding stage in the replication cycle of C. trachomatis (; ; ), and we found that both the budding and septation phases of the process appear to exhibit the highest rates of PG synthesis, as measured by active incorporation of our labeling probe. These observations suggest that a high degree of PG synthesis activity is characteristic of both the expansion and constriction stages of the PG ring at the initiation and termination of cell division, respectively.
Figure 8
Researchers have hypothesized that Chlamydia MreB is capable of directing septal PG biosynthesis in the absence of FtsZ (; ), and a recent study has demonstrated that Chlamydia MreB is capable of directing septal PG biosynthesis in an Escherichia coli strain lacking both MreB and FtsZ activity, effectively enabling this strain to divide in the absence of FtsZ (). The ability of the Chlamydia MreB protein (MreBCT) to effectively direct PG synthesis to the septum in E. coli was dependent on the co-expressing of the Chlamydia RodZ protein (RodZCT), indicating that these two Chlamydia proteins are sufficient to direct septal PG synthesis not only in C. trachomatis, but also in surrogate systems. Researchers have previously established that MreB and RodZ are important for directing PG biosynthesis in C. trachomatis, and it has been proposed that MreB directs both PG synthases in these organisms (; ; ). We found it interesting that despite inhibiting MreB activity, we were still able to observe trace amounts of PG labeling. PG-labeled objects subsequent to MP265 treatment, on average, tended to have smaller volumes and lower mean fluorescent intensities then untreated controls. Previous work investigating the dissociation of the C. trachomatis PG ring complex noted that even after dissociation single PG-positive puncta were nearly always observable (). This suggests that while MreB polymerization is essential for the construction of the chlamydial PG septum, some PG synthesis still occurs in the absence of this process. Alternatively, PG in the vicinity of the divisome complex may simply be spatially protected from degradation by the bacterium’s PG hydrolysis enzymes.
PG biosynthesis and degradation pathways are decoupled in C. trachomatis, and inhibition of new synthesis results in the rapid degradation of the PG ring (). In conducting our analysis of PG-containing structures, we had originally assumed that MreBCT was capable of directing both the RodA-PBP2 and FtsW-PBP3 PG polymerase complexes in Chlamydia. Interestingly, we found that when chlamydial PBP2 and PBP3 functions are inhibited separately, significant differences in PG probe incorporation occur (Figure 4). When either MreB or PBP2 function is selectively inhibited, the majority of the PG ring dissociates, however, some PG-labeled foci remain. When accounting for differences in volume (Figure 4C, mean intensity) these foci have comparable levels of PG synthesis activity to untreated and piperacillin-treated controls. These observations are consistent with localized, PG synthesis in the absence of PBP2 activity. By contrast, inhibition of PBP3 results in the accumulation of large PG-containing structures and an aberrant ring morphology similar to that observed upon treatment with ampicillin (, ; ). Interestingly, mean fluorescent intensities of PG-labeled objects in both mecillinam- and piperacillin-treated groups were slightly elevated compared to untreated controls.
When subjected to penicillin and D-cycloserine, bacterial cells often futilely attempt to overcome the perceived defect in their PG synthesis activity by enhancing the production of PG precursor molecules (). As these PG precursors are highly detectable by our innate immune system, this effect can be observed by measuring signaling of NOD1 and NOD2 receptors (). Utilizing our NOD1 reporter assay, we found that treatment with PBP2- and PBP3-specific inhibitors did not significantly enhance the turnover and shedding of PG-derived muropeptides by C. trachomatis while treatment with penicillin G and D-cycloserine did (Figure 5). We took this as evidence that penicillin G is broadly affecting multiple PBPs in C. trachomatis, whereas piperacillin and mecillinam appear to be more targeted. D-cycloserine effectively prevents PG biosynthesis at a stage prior to transpeptidation, and therefore, it also significantly enhances NOD stimulation. As our ampicillin treatment group exhibits labeling and immunostimulatory profiles more similar to that of our piperacillin treatment condition, we reason that ampicillin (unlike penicillin G) preferentially inhibits PBP3 in C. trachomatis.
Given these differences, we propose that the two chlamydial PG synthases differ in their activities and likely determine PG ring dimensions during cell division (Figure 8B). A previous study found that PG synthesis via PBP2 was necessary to initiate polarized division in C. trachomatis (), indicating that the PBP2-specific PG ring expansion we characterize in our study is likely essential to this initial division process. We postulate that RodA-PBP2 and FtsW-PBP3 complexes function independently during division and that the differences we observe in labeling localization represent either differences in the location of synthesized PG or that the stability of the PG each synthase generates is inherently different. Given the assumption that PG is a transient structure in Chlamydia species, differences in the relative activities of these two synthases would largely explain changes in PG ring dimensions throughout the division cycle (Figure 8B). When combined with our overall assessment of PG localization during the Chlamydia division process, we reason that the enhanced labeling we observe during the expansion and constriction of the PG ring is largely due to increased PBP2 and PBP3 activities, respectively.
Our observation that PG ring volume and labeling intensity decrease with time is consistent with the previously proposed cell size-precedes cell differentiation model of C. trachomatis development (). Assuming a linear function, we calculate that the average PG-labeled object in an inclusion two microns in diameter (our smallest observed inclusion size) to have an average volume of ~0.047 um3, whereas the average PG-labeled object present in an inclusion 13μ in diameter (our largest observed inclusion size) would have an average volume of ~0.016 um3. For comparison, Lee et al. found that compared to RB size at 12h post-infection, average RB volume decreased by roughly half by 24hpi and by roughly three quarters by 32hpi ().
Because C. trachomatis replicates more rapidly at later developmental stages, it is possible that our observation that PG-labeled objects are smaller later in development is due to the presence of greater numbers of early (budding) and late (septation) division stages with the characteristic smaller PG rings. However, we posit that if there are greater numbers of smaller rings due to bacteria actively synthesizing PG and undergoing budding and septation, then we should have seen corresponding higher relative PG fluorescence mean intensity values, a readout of object density (Figure 2). Because this does not appear to be the case in larger, more mature inclusions (Figure 7B), we conclude that our data support cell size reduction of PG-containing C. trachomatis RBs over the span of the pathogen’s developmental cycle. The underlying cause of this decrease in average PG mean intensity throughout the development of C. trachomatis is unknown, but may be a function of competing metabolic processes, the availability of some concentration-dependent nutrient, or simply the fact that the essential PG density required for budding/septation differs depending on cell size. Future studies will be needed to further elucidate how cell size affects basic metabolic processes such as PG synthesis and turnover in Chlamydia species.
Funding
This work was supported by a MIRA ESI award (R35 GM138202) and a USU faculty start up award (HP73LIEC18) to GL. The funders had no role in study design, data collection, and interpretation or the decision to submit the work for publication. The opinions and assertions expressed herein are those of the author and do not necessarily reflect the official policy or position of the Uniformed Services University or the Department of Defense.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Author contributions
GL: conceptualization and design, data curation, formal analysis, investigation, methodology, validation, visualization, writing, editing, funding acquisition, and project administration.
Acknowledgments
I would like to thank my long-time collaborator Dr. Michael VanNieuwenhze (Indiana University) and his laboratory for providing us with the “clickable” D-alanine dipeptides (EDA-DA) used in our peptidoglycan-labeling experiments.
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AbdelrahmanY.OuelletteS. P.BellandR. J.CoxJ. V. (2016). Polarized cell division of Chlamydia trachomatis. PLoS Pathog.12:e1005822. doi: 10.1371/journal.ppat.1005822
2
BarbourA. G.AmanoK.HackstadtT.PerryL.CaldwellH. D. (1982). Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J. Bacteriol.151, 420–428. doi: 10.1128/jb.151.1.420-428.1982
3
BeattyW. L.MorrisonR. P.ByrneG. I. (1994). Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol. Rev.58, 686–699. doi: 10.1128/mr.58.4.686-699.1994
4
BellandR. J.NelsonD. E.VirokD.CraneD. D.HoganD.SturdevantD.et al. (2003). Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. Proc. Natl. Acad. Sci. U. S. A.100, 15971–15976. doi: 10.1073/pnas.2535394100
5
BonnerC. A.ByrneG. I.JensenR. A. (2014). Chlamydia exploit the mammalian tryptophan-depletion defense strategy as a counter-defensive cue to trigger a survival state of persistence. Front. Cell. Infect. Microbiol.4:17. doi: 10.3389/fcimb.2014.00017
6
BrinkworthA. J.WildungM. R.CarabeoR. A. (2018). Genomewide transcriptional responses of iron-starved Chlamydia trachomatis reveal prioritization of metabolic precursor synthesis over protein translation. mSystems, 3, e00184–e001817. doi: 10.1128/mSystems.00184-17
7
BrockettM. R.LiechtiG. W. (2021). Persistence alters the interaction between Chlamydia trachomatis and its host cell. Infect. Immun.89:e0068520. doi: 10.1128/IAI.00685-20
8
BrothwellJ. A.BrockettM.BanerjeeA.SteinB. D.NelsonD. E.LiechtiG. W. (2021). Genome copy number regulates inclusion expansion, septation, and infectious developmental form conversion in Chlamydia trachomatis. J. Bacteriol.203, e00630–e006320. doi: 10.1128/JB.00630-20
9
ChoH.UeharaT.BernhardtT. G. (2014). Beta-lactam antibiotics induce a lethal malfunctioning of the bacterial cell wall synthesis machinery. Cell159, 1300–1311. doi: 10.1016/j.cell.2014.11.017
10
CoxJ. V.AbdelrahmanY. M.OuelletteS. P. (2020). Penicillin-binding proteins regulate multiple steps in the polarized cell division process of Chlamydia. Sci. Rep.10:12588. doi: 10.1038/s41598-020-69397-x
11
EganA. J.VollmerW. (2013). The physiology of bacterial cell division. Ann. N. Y. Acad. Sci.1277, 8–28. doi: 10.1111/j.1749-6632.2012.06818.x
12
ElwellC.MirrashidiK.EngelJ. (2016). Chlamydia cell biology and pathogenesis. Nat. Rev. Microbiol.14, 385–400. doi: 10.1038/nrmicro.2016.30
13
FalcieriE.CeveniniR.LandiniM. P.DonatiM. (1979). The replication cycle of Chlamydia trachomatis and Chlamydia psittaci: ultrastructural analysis. Boll. Ist. Sieroter. Milan.58, 395–405. PMID:
14
FengG. S.TaylorM. W. (1989). Interferon gamma-resistant mutants are defective in the induction of indoleamine 2,3-dioxygenase. Proc. Natl. Acad. Sci. U. S. A.86, 7144–7148. doi: 10.1073/pnas.86.18.7144
15
FoxA.RogersJ. C.GilbartJ.MorganS.DavisC. H.KnightS.et al. (1990). Muramic acid is not detectable in Chlamydia psittaci or Chlamydia trachomatis by gas chromatography-mass spectrometry. Infect. Immun.58, 835–837. doi: 10.1128/iai.58.3.835-837.1990
16
FuerstJ. A. (1995). The planctomycetes: emerging models for microbial ecology, evolution and cell biology. Microbiology141, 1493–1506. doi: 10.1099/13500872-141-7-1493
17
GarrettA. J.HarrisonM. J.ManireG. P. (1974). A search for the bacterial mucopeptide component, muramic acid, in Chlamydia. J. Gen. Microbiol.80, 315–318. doi: 10.1099/00221287-80-1-315
18
GaylordW. H.Jr. (1954). Intracellular forms of meningopneumonitis virus. J. Exp. Med.100, 575–580. doi: 10.1084/jem.100.6.575
19
GogolakF. M.WeissE. (1950). The effect of antibiotics on agents of the psittacosis-lymphogranuloma group. J. Infect. Dis.87, 264–274. doi: 10.1093/infdis/87.3.264
20
GrayA. N.EganA. J.Van't VeerI. L.VerheulJ.ColavinA.KoumoutsiA.et al. (2015). Coordination of peptidoglycan synthesis and outer membrane constriction during Escherichia coli cell division. elife4:e07118. doi: 10.7554/eLife.07118
21
HackstadtT.RockeyD. D.HeinzenR. A.ScidmoreM. A. (1996). Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J.15, 964–977. doi: 10.1002/j.1460-2075.1996.tb00433.x
22
HarperA.PogsonC. I.JonesM. L.PearceJ. H. (2000). Chlamydial development is adversely affected by minor changes in amino acid supply, blood plasma amino acid levels, and glucose deprivation. Infect. Immun.68, 1457–1464. doi: 10.1128/IAI.68.3.1457-1464.2000
23
HurstE. W.LandquistJ. K.MelvinP.PetersJ. M.SeniorN.SilkJ. A.et al. (1953). The therapy of experimental psittacosis and lymphogranuloma venereum (inguinale) II. The activity of quinoxaline-1:4-dioxide and substituted and related compounds, with a note on the morphological changes induced in lymphogranuloma virus by these compounds and by antibiotics. Br. J. Pharmacol. Chemother.8, 297–305. doi: 10.1111/j.1476-5381.1953.tb00798.x
24
HybiskeK.StephensR. S. (2007). Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc. Natl. Acad. Sci. U. S. A.104, 11430–11435. doi: 10.1073/pnas.0703218104
25
JacquierN.FrandiA.PillonelT.ViollierP. H.GreubG. (2014). Cell wall precursors are required to organize the chlamydial division septum. Nat. Commun.5:3578. doi: 10.1038/ncomms4578
26
KawaiY.MickiewiczK.ErringtonJ. (2018). Lysozyme counteracts beta-lactam antibiotics by promoting the emergence of L-form bacteria. Cell172:e1010. doi: 10.1016/j.cell.2018.01.021
27
KemegeK. E.HickeyJ. M.BartaM. L.WickstrumJ.BalwalliN.LovellS.et al. (2015). Chlamydia trachomatis protein CT009 is a structural and functional homolog to the key morphogenesis component RodZ and interacts with division septal plane localized MreB. Mol. Microbiol.95, 365–382. doi: 10.1111/mmi.12855
28
KuruE.RadkovA.MengX.EganA.AlvarezL.DowsonA.et al. (2019). Mechanisms of incorporation for D-amino acid probes that target peptidoglycan biosynthesis. ACS Chem. Biol.14, 2745–2756. doi: 10.1021/acschembio.9b00664
29
LambdenP. R.PickettM. A.ClarkeI. N. (2006). The effect of penicillin on Chlamydia trachomatis DNA replication. Microbiology152, 2573–2578. doi: 10.1099/mic.0.29032-0
30
LeeJ. K.EncisoG. A.BoassaD.ChanderC. N.LouT. H.PairawanS. S.et al. (2018). Replication-dependent size reduction precedes differentiation in Chlamydia trachomatis. Nat. Commun.9:45. doi: 10.1038/s41467-017-02432-0
31
LeeK. C.WebbR. I.FuerstJ. A. (2009). The cell cycle of the planctomycete Gemmata obscuriglobus with respect to cell compartmentalization. BMC Cell Biol.10:4. doi: 10.1186/1471-2121-10-4
32
LewisM. E.BellandR. J.AbdelRahmanY. M.BeattyW. L.AiyarA. A.ZeaA. H.et al. (2014). Morphologic and molecular evaluation of Chlamydia trachomatis growth in human endocervix reveals distinct growth patterns. Front. Cell. Infect. Microbiol.4:71. doi: 10.3389/fcimb.2014.00071
33
LiechtiG. W.KuruE.HallE.KalindaA.BrunY. V.VanNieuwenhzeM.et al. (2014). A new metabolic cell-wall labelling method reveals peptidoglycan in Chlamydia trachomatis. Nature506, 507–510. doi: 10.1038/nature12892
34
LiechtiG.KuruE.PackiamM.HsuY. P.TekkamS.HallE.et al. (2016). Pathogenic Chlamydia lack a classical Sacculus but synthesize a narrow, mid-cell peptidoglycan ring, regulated by MreB, for cell division. PLoS Pathog.12:e1005590. doi: 10.1371/journal.ppat.1005590
35
LinH. S.MoulderJ. W. (1966). Patterns of response to sulfadiazine, D-cycloserine and D-alanine in members of the psittacosis group. J. Infect. Dis.116, 372–376. doi: 10.1093/infdis/116.3.372
36
MeeskeA. J.RileyE. P.RobinsW. P.UeharaT.MekalanosJ. J.KahneD.et al. (2016). SEDS proteins are a widespread family of bacterial cell wall polymerases. Nature537, 634–638. doi: 10.1038/nature19331
37
MercierR.KawaiY.ErringtonJ. (2014). General principles for the formation and proliferation of a wall-free (L-form) state in bacteria. elife3:e04629. doi: 10.7554/eLife.04629
38
MoulderJ. W. (1993). Why is Chlamydia sensitive to penicillin in the absence of peptidoglycan?Infect. Agents Dis.2, 87–99. PMID:
39
MoulderJ. W.NovoselD. L.OfficerJ. E. (1963). Inhibition of the growth of agents of the psittacosis group by D-Cycloserine and its specific reversal by D-alanine. J. Bacteriol.85, 707–711. doi: 10.1128/jb.85.3.707-711.1963
40
OuelletteS. P.KarimovaG.SubtilA.LadantD. (2012). Chlamydia co-opts the rod shape-determining proteins MreB and Pbp2 for cell division. Mol. Microbiol.85, 164–178. doi: 10.1111/j.1365-2958.2012.08100.x
41
OuelletteS. P.LeeJ.CoxJ. V. (2020). Division without binary fission: cell division in the FtsZ-less Chlamydia. J. Bacteriol.202, e00252–e002520. doi: 10.1128/JB.00252-20
42
OuelletteS. P.RuedenK. J.GauliardE.PersonsL.de BoerP. A.LadantD. (2014). Analysis of MreB interactors in Chlamydia reveals a RodZ homolog but fails to detect an interaction with MraY. Front. Microbiol.5:279. doi: 10.3389/fmicb.2014.00279
43
PackiamM.WeinrickB.JacobsW. R.Jr.MaurelliA. T. (2015). Structural characterization of muropeptides from Chlamydia trachomatis peptidoglycan by mass spectrometry resolves “chlamydial anomaly”, Proc. Natl. Acad. Sci. U. S. A.112, 11660–11665. doi: 10.1073/pnas.1514026112
44
PanzettaM. E.ValdiviaR. H.SakaH. A. (2018). Chlamydia persistence: a survival strategy to evade antimicrobial effects in-vitro and in-vivo. Front. Microbiol.9:3101. doi: 10.3389/fmicb.2018.03101
45
PhillipsD. M.SwensonC. E.SchachterJ. (1984). Ultrastructure of Chlamydia trachomatis infection of the mouse oviduct. J. Ultrastruct. Res.88, 244–256. doi: 10.1016/S0022-5320(84)90122-9
46
PilhoferM.AistleitnerK.BiboyJ.GrayJ.KuruE.HallE.et al. (2013). Discovery of chlamydial peptidoglycan reveals bacteria with murein sacculi but without FtsZ. Nat. Commun.4:2856. doi: 10.1038/ncomms3856
47
RanjitD. K.LiechtiG. W.MaurelliA. T. (2020). Chlamydial MreB directs cell division and peptidoglycan synthesis in Escherichia coli in the absence of FtsZ activity. mBio11, e03222–e032219. doi: 10.1128/mBio.03222-19
48
Santarella-MellwigR.PruggnallerS.RoosN.MattajI. W.DevosD. P. (2013). Three-dimensional reconstruction of bacteria with a complex endomembrane system. PLoS Biol.11:e1001565. doi: 10.1371/journal.pbio.1001565
49
ShiH.WestfallC. S.KaoJ.OdermattP. D.AndersonS. E.CesarS.et al. (2021). Starvation induces shrinkage of the bacterial cytoplasm. Proc. Natl. Acad. Sci. U. S. A.118:e2104686118. doi: 10.1073/pnas.2104686118
50
SinghR.LiechtiG.SladeJ. A.MaurelliA. T. (2020). Chlamydia trachomatis oligopeptide transporter performs dual functions of oligopeptide transport and peptidoglycan recycling. Infect. Immun.88, e00086–e000820. doi: 10.1128/IAI.00086-20
51
SladeJ. A.BrockettM.SinghR.LiechtiG. W.MaurelliA. T. (2019). Fosmidomycin, an inhibitor of isoprenoid synthesis, induces persistence in Chlamydia by inhibiting peptidoglycan assembly. PLoS Pathog.15:e1008078. doi: 10.1371/journal.ppat.1008078
52
StephensR. S.KalmanS.LammelC.FanJ.MaratheR.AravindL.et al. (1998). Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science282, 754–759. doi: 10.1126/science.282.5389.754
53
SwansonJ.EschenbachD. A.AlexanderE. R.HolmesK. K. (1975). Light and electron microscopic study of Chlamydia trachomatis infection of the uterine cervix. J. Infect. Dis.131, 678–687. doi: 10.1093/infdis/131.6.678
54
TaguchiA.WelshM. A.MarmontL. S.LeeW.SjodtM.KruseA. C.et al. (2019). FtsW is a peptidoglycan polymerase that is functional only in complex with its cognate penicillin-binding protein. Nat. Microbiol.4, 587–594. doi: 10.1038/s41564-018-0345-x
55
TamuraA.ManireG. P. (1967). Preparation and chemical composition of the cell membranes of developmental reticulate forms of meningopneumonitis organisms. J. Bacteriol.94, 1184–1188. doi: 10.1128/jb.94.4.1184-1188.1967
56
TanamiY.YamadaY. (1973). Miniature cell formation in Chlamydia psittaci. J. Bacteriol.114, 408–412. doi: 10.1128/jb.114.1.408-412.1973
57
VadiaS.TseJ. L.LucenaR.YangZ.KelloggD. R.WangJ. D.et al. (2017). Fatty acid availability sets cell envelope capacity and dictates microbial cell size. Curr. Biol.27, 1757.e5–1767.e5. doi: 10.1016/j.cub.2017.05.076
58
WeissE. (1950). The effect of antibiotics on agents of the psittacosis-lymphogranuloma group. I. The effect of penicillin. J. Infect. Dis.87, 249–263. doi: 10.1093/infdis/87.3.249
59
Welter-StahlL.OjciusD. M.VialaJ.GirardinS.LiuW.DelarbreC.et al. (2006). Stimulation of the cytosolic receptor for peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia muridarum. Cell. Microbiol.8, 1047–1057. doi: 10.1111/j.1462-5822.2006.00686.x
60
WolfK.FischerE.HackstadtT. (2000). Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells. Infect. Immun.68, 2379–2385. doi: 10.1128/IAI.68.4.2379-2385.2000
61
WyrickP. B. (2010). Chlamydia trachomatis persistence in vitro: an overview. J. Infect. Dis.201, 88–95. doi: 10.1086/652394
Summary
Keywords
cell division, cell size regulation, Chlamydia, peptidoglycan, pathoadaptation
Citation
Liechti GW (2021) Localized Peptidoglycan Biosynthesis in Chlamydia trachomatis Conforms to the Polarized Division and Cell Size Reduction Developmental Models. Front. Microbiol. 12:733850. doi: 10.3389/fmicb.2021.733850
Received
30 June 2021
Accepted
17 November 2021
Published
09 December 2021
Volume
12 - 2021
Edited by
Shishen Du, Wuhan University, China
Reviewed by
Nicolas Jacquier, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland; Scott Hefty, University of Kansas, United States
Updates
Copyright
© 2021 Liechti.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: George W. Liechti, george.liechti@usuhs.edu
This article was submitted to Microbial Physiology and Metabolism, a section of the journal Frontiers in Microbiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.